JOHN MCGRATH Insider Trading $ATRA Atara Biotherapeutics, Inc.
Get free email notifications about insider trading for JOHN MCGRATH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MCGRATH. JOHN MCGRATH is CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and EXC.112.VP CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and VP & CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and VP CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and VP, CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and Director in ENDWAVE CORP ($ENWV) and Chief Financial Officer in Atara Biotherapeutics, Inc. ($ATRA) and EVP & Chief Financial Officer in Atara Biotherapeutics, Inc. ($ATRA).
JOHN MCGRATH in Atara Biotherapeutics, Inc.
Trading Symbol: ATRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MCGRATH: EVP & Chief Financial Officer, Chief Financial Officer
Holdings: 91,762 shares
Current Value: $1,381,018
Latest Transaction: Mar 20 2018
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN MCGRATH in Atara Biotherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRA, ENWV, NWK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 38.83 | 3,000 | 116,490 | 88,762 | 91.8 K to 88.8 K (-3.27 %) |
Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 41.99 | 3,000 | 125,970 | 91,762 | 94.8 K to 91.8 K (-3.17 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 5,132 | 0 | 0 | |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 48.08 | 2,500 | 120,200 | 94,762 | 97.3 K to 94.8 K (-2.57 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 46.93 | 4,000 | 187,720 | 97,262 | 101.3 K to 97.3 K (-3.95 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Payment of Exercise | F | 47.05 | 2,926 | 137,668 | 101,262 | 104.2 K to 101.3 K (-2.81 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 5,132 | 0 | 104,188 | 99.1 K to 104.2 K (+5.18 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 46.77 | 6,500 | 304,005 | 99,056 | 105.6 K to 99.1 K (-6.16 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Payment of Exercise | F | 41.70 | 4,819 | 200,952 | 105,556 | 110.4 K to 105.6 K (-4.37 %) |
Feb 08 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | A | 35.80 | 50,000 | 1,790,000 | 50,000 | |
Feb 08 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Payment of Exercise | F | 35.80 | 4,279 | 153,188 | 110,375 | 114.7 K to 110.4 K (-3.73 %) |
Feb 08 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Grant | A | 0.00 | 25,000 | 0 | 114,654 | 89.7 K to 114.7 K (+27.88 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 11.00 | 30,000 | 330,000 | 10,000 | |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 25.00 | 30,000 | 750,000 | 89,654 | 119.7 K to 89.7 K (-25.07 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 22.32 | 3,500 | 78,120 | 119,654 | 123.2 K to 119.7 K (-2.84 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 11.00 | 30,000 | 330,000 | 123,154 | 93.2 K to 123.2 K (+32.20 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.77 | 3,500 | 72,695 | 93,154 | 96.7 K to 93.2 K (-3.62 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.00 | 32,000 | 640,000 | 96,654 | 128.7 K to 96.7 K (-24.87 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 5,132 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 128,654 | 121 K to 128.7 K (+6.36 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 12,829 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.39 | 2,100 | 30,219 | 120,957 | 123.1 K to 121 K (-1.71 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.23 | 2,100 | 29,883 | 123,057 | 125.2 K to 123.1 K (-1.68 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 125,157 | 117.5 K to 125.2 K (+6.55 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,698 | 0 | 20,526 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 935 | 0 | 0 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 15.27 | 2,000 | 30,540 | 117,460 | 119.5 K to 117.5 K (-1.67 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.95 | 2,000 | 29,900 | 119,460 | 121.5 K to 119.5 K (-1.65 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,698 | 0 | 121,460 | 113.8 K to 121.5 K (+6.77 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 935 | 0 | 113,762 | 112.8 K to 113.8 K (+0.83 %) |
Mar 23 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 21.08 | 6,500 | 137,020 | 112,827 | 119.3 K to 112.8 K (-5.45 %) |
Mar 23 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.27 | 7,500 | 152,025 | 119,327 | 126.8 K to 119.3 K (-5.91 %) |
Mar 10 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.00 | 24,000 | 480,000 | 126,827 | 150.8 K to 126.8 K (-15.91 %) |
Feb 22 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 15.14 | 9,000 | 136,260 | 150,827 | 159.8 K to 150.8 K (-5.63 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 28,224 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 2,804 | 0 | 935 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 159,827 | 152.1 K to 159.8 K (+5.06 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 2,804 | 0 | 152,130 | 149.3 K to 152.1 K (+1.88 %) |
Feb 08 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Grant | A | 0.00 | 49,500 | 0 | 149,326 | 99.8 K to 149.3 K (+49.59 %) |
Nov 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,698 | 0 | 35,921 | |
Nov 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,805 | 0 | 3,739 | |
Nov 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,698 | 0 | 99,826 | 92.1 K to 99.8 K (+8.36 %) |
Nov 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,805 | 0 | 92,128 | 89.3 K to 92.1 K (+3.14 %) |
Nov 14 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 19.37 | 2,500 | 48,425 | 89,323 | 91.8 K to 89.3 K (-2.72 %) |
Nov 14 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 20.30 | 2,500 | 50,750 | 91,823 | 94.3 K to 91.8 K (-2.65 %) |
Oct 13 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 16.41 | 2,500 | 41,025 | 94,323 | 96.8 K to 94.3 K (-2.58 %) |
Oct 13 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 18.52 | 2,500 | 46,300 | 96,823 | 99.3 K to 96.8 K (-2.52 %) |
Aug 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,697 | 0 | 43,619 | |
Aug 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,804 | 0 | 6,544 | |
Aug 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,697 | 0 | 99,323 | 91.6 K to 99.3 K (+8.40 %) |
Aug 17 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,804 | 0 | 91,626 | 88.8 K to 91.6 K (+3.16 %) |
May 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,698 | 0 | 51,316 | |
May 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,805 | 0 | 9,348 | |
May 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 15.77 | 5,395 | 85,079 | 88,822 | 94.2 K to 88.8 K (-5.73 %) |
May 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,698 | 0 | 94,217 | 86.5 K to 94.2 K (+8.90 %) |
May 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,805 | 0 | 86,519 | 83.7 K to 86.5 K (+3.35 %) |
Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,697 | 0 | 59,014 | |
Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,804 | 0 | 12,153 | |
Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 15.49 | 6,000 | 92,940 | 83,714 | 89.7 K to 83.7 K (-6.69 %) |
Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,697 | 0 | 89,714 | 82 K to 89.7 K (+9.38 %) |
Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,804 | 0 | 82,017 | 79.2 K to 82 K (+3.54 %) |
Feb 11 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Grant | A | 0.00 | 42,857 | 0 | 79,213 | 36.4 K to 79.2 K (+117.88 %) |
Dec 21 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | A | 22.72 | 65,000 | 1,476,800 | 65,000 | |
Dec 01 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 40.00 | 6,000 | 240,000 | 36,356 | 42.4 K to 36.4 K (-14.17 %) |
Nov 18 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,697 | 0 | 66,711 | |
Nov 18 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,805 | 0 | 14,957 | |
Nov 18 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,697 | 0 | 42,356 | 34.7 K to 42.4 K (+22.21 %) |
Nov 18 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,805 | 0 | 34,659 | 31.9 K to 34.7 K (+8.81 %) |
Aug 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,698 | 0 | 74,408 | |
Aug 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,804 | 0 | 17,762 | |
Aug 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 49.38 | 6,000 | 296,280 | 31,854 | 37.9 K to 31.9 K (-15.85 %) |
Aug 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,698 | 0 | 37,854 | 30.2 K to 37.9 K (+25.53 %) |
Aug 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,804 | 0 | 30,156 | 27.4 K to 30.2 K (+10.25 %) |
Jun 16 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 50.00 | 10,000 | 500,000 | 27,352 | 37.4 K to 27.4 K (-26.77 %) |
Jun 01 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 40.00 | 10,000 | 400,000 | 37,352 | 47.4 K to 37.4 K (-21.12 %) |
May 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 41,052 | 0 | 82,106 | |
May 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 24,305 | 0 | 20,566 | |
May 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Payment of Exercise | F | 37.30 | 30,405 | 1,134,107 | 47,352 | 77.8 K to 47.4 K (-39.10 %) |
May 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 41,052 | 0 | 77,757 | 36.7 K to 77.8 K (+111.84 %) |
May 19 2015 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 24,305 | 0 | 36,705 | 12.4 K to 36.7 K (+196.01 %) |
Page: 1